Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic, in collaboration with Professor Benabid and Professor Pollak, started developing deep brain stimulation in 1987 and has been the leader in the field ever since. Your Medtronic DBS will be backed by our decades of research, innovation, and experience.
Medtronic is a global leader in medical technology, services, and solutions — serving millions of people around the world every day. Since 1949 your best health is what has been driving us.
With an eye on driving down healthcare costs through innovation, we create therapies that alleviate pain, restore health, and extend life for people around the world. We also go beyond therapies, using our technology and expertise to help doctors and hospitals provide better, more efficient care.
Medtronic DBS has been studied by clinical researchers for decades. DBS is not an experimental or brand new medical treatment.
Medtronic DBS therapy is supported by five Level 1 clinical studies — the highest quality of evidence.
We’re dedicated to proving the value of DBS therapy. That’s why we partnered with over 10,000 people with Parkinson’s for clinical trials and published over 2,100 original clinical publications.
We know it's important that you have safe access to MRI if you need this important test to diagnose a medical condition or injury.1 That's why we performed rigorous testing.
There is a good chance — as much as 70% — that you will need an MRI within 10 years of treatment. Today, it is the preferred mode of diagnostic imaging for many disease states. So we have developed the world’s first full-body MRI-capable DBS device portfolio. Take comfort in knowing that with the proper safeguards, you can receive an MRI scan with your DBS implant should you ever need one.
*Based on recommendations by European and national medical societies. Analyses based on Parkinson's disease comorbidities recommended for MRI in Europe, the % was calculated for a real-life Parkinson's disease population potentially eligible for DBS, from US commercial health insurance database (Conroy et al, conference presentation, ECR 2015, Vienna)
Our new device, the PerceptTM PC neurostimulator, features BrainsenseTM technology. This innovative technology captures brain signal data direct from your implanted leads. It then stores the data, so your physician can access it.*
Using this data, your physician may adjust your settings - personalising your therapy for the best possible outcome.**
*Signal may not be present or measurable in all patients.
** Clinical benefits of brain sensing have not been established.
Travel the world — we have you covered. Medtronic DBS is available in 73 countries worldwide, allowing you to be treated almost anywhere you go.
Know you’re in good hands. We have partnered with more than 1,200 hospitals to enable access to our life-improving products to Parkinson’s sufferers worldwide.
And your data travels with you — it is stored in the stimulator to prevent programmer loss or damage.
Medtronic DBS systems are MR Conditional, which means they are safe for MRI scans only under certain conditions. If the conditions are not met, the MRI could cause tissue heating especially at the implanted lead(s) in the brain, which may result in serious and permanent injury or death. Before having an MRI, always talk with the doctor who manages your DBS therapy to determine your eligibility and discuss potential benefits and risks of MRI.